| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA643971 | F | KB for reversal of adenylate cyclase inhibition by (R)-N6-(2-[3H]-phenyl-1-methylethyladenosine in rat adipocytes | Rattus norvegicus | 1 | cell-based format | Scientific Literature | ||
| 2. | ALA645311 | B | Compound was evaluated for inhibition of hormone stimulated Adenylate cyclase activity in N18TG2 membranes. | Mus musculus | 4 | cell membrane format | Scientific Literature | ||
| 3. | ALA645373 | B | Effective concentration as Adenylate cyclase activity was measured in rat homogenate | Rattus norvegicus | 11 | assay format | Scientific Literature | ||
| 4. | ALA645374 | B | Compound was evaluated for inhibition of adenylate cyclase from rat brain | Rattus norvegicus | 7 | tissue-based format | Scientific Literature | ||
| 5. | ALA645376 | B | Concentration that reduces by 50% the rat striatal dopamine (D1) sensitive adenylate cyclase activity; ND means no data | Rattus norvegicus | 2 | single protein format | Scientific Literature | ||
| 6. | ALA645377 | F | Intrinsic activity measured as ability to stimulate dopamine sensitive Adenylate cyclase activity was measured in rat striatum. | Rattus norvegicus | 11 | tissue-based format | Scientific Literature | ||
| 7. | ALA645378 | F | Percent stimulation ofcAMP production was measured in vitro using rat liver plasma membrane bioassay | Rattus norvegicus | 3 | cell-free format | Scientific Literature | ||
| 8. | ALA646258 | F | Percent stimulation ofcAMP production was measured in vitro using rat liver plasma membrane bioassay; none | Rattus norvegicus | 4 | cell-free format | Scientific Literature | ||
| 9. | ALA646264 | B | Effective concentration against adenylate cyclase | 1 | single protein format | Scientific Literature | |||
| 10. | ALA646265 | B | Effective concentration against adenylate cyclase; NA= not applicable | 2 | single protein format | Scientific Literature | |||
| 11. | ALA646267 | F | Tested for effective dose agonist activity against adenylate cyclase in rat striatal membrane | 1 | cell membrane format | Scientific Literature | |||
| 12. | ALA646270 | B | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 5 moles | 1 | assay format | Scientific Literature | |||
| 13. | ALA646271 | B | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 5.4 moles | 1 | assay format | Scientific Literature | |||
| 14. | ALA644604 | B | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 5.7 moles | 1 | assay format | Scientific Literature | |||
| 15. | ALA644605 | B | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 6 moles | 1 | assay format | Scientific Literature | |||
| 16. | ALA644606 | B | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 6.8 moles | 1 | assay format | Scientific Literature | |||
| 17. | ALA644607 | B | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 7 moles | 1 | assay format | Scientific Literature | |||
| 18. | ALA644608 | B | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 7.2 moles | 1 | assay format | Scientific Literature | |||
| 19. | ALA644609 | B | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 7.6 moles | 1 | assay format | Scientific Literature | |||
| 20. | ALA644610 | B | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 8 moles | 1 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!